The leading source for credible citizen reporting

Report Your News
Take the tour...

Salk Institute Awarded Grant For ALS Project

Source: 10 News
San Diego : CA : USA | about 1 month ago  
Views: 0
The Salk Institute in La Jolla was awarded a $10.8 million state grant to develop a stem-cell derived therapy for Lou Gehrig's disease, it was announced Wednesday. The grant was among $250 million awarded by the California Institute for Regenerative Medicine, which was created to oversee...
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: The New York Times | about 1 month ago
    In a tacit acknowledgment that the promise of human embryonic stem cells is still far in the future, California’s stem cell research program on Wednesday awarded grants intended to develop therapies using mainly other, less controversial cells...
  • News Source: 10 News | about 1 month ago
    The Moores UC San Diego Cancer Center has been awarded a four-year, $20 million state grant to develop drugs that would thwart leukemia stem cells, it was announced Wednesday. Cancer Center will collaborate with a Canadian research tem lead by...
  • News Source: 10 News | about 1 month ago
    The Salk Institute in La Jolla was awarded a $10.8 million state grant to develop a stem-cell derived therapy for Lou Gehrig's disease, it was announced Wednesday. The grant was among $250 million awarded by the California Institute for Regenerative...
  • News Source: San Diego Union-Tribune | about 1 month ago
    The state's stem cell institute approved $230 million in grants Wednesday, including $55.6 million for projects that will be based in San Diego. The 14 grants the institute awarded statewide will go to multidisciplinary research teams — typically...
  • News Source: San Diego Union-Tribune | about 1 month ago
    The faltering biotechnology company Metabasis Therapeutics said yesterday that it has agreed to a takeover by the larger San Diego company Ligand Pharmaceuticals. Metabasis, which cut its staff to seven people this year as it ran low on cash, said it...
Blogs
 >
  • Blog Source: www.firstthings.com
    In a tacit acknowledgment that the promise of human embryonic stem cells is still far in the future, California*s stem cell research program on Wednesday awarded grants intended to develop therapies using mainly other, ...
  • Blog Source: www.washingtonexaminer.com
    Ligand Pharmaceuticals Inc. will buy Metabasis Therapeutics Inc. for about $3.2 million and contingent future payments, the companies said Tuesday.
  • Blog Source: www.stemcelltracker.com
    Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ...
  • Blog Source: www.onemedplace.com
    San Diego-based Ligand has agreed to spend $8 million on research and development programs for Metabasis. Ligand is partnered with a number of large pharmaceutical companies, including Wyeth and Pfizer, on a variety of drug development ...
  • Blog Source: www.socaltech.com
    San Diego-based biopharmaceuticals firms Ligand Pharmaceuticals and Metabasis Therapeutics announced this morning that Ligand is acquiring Metabasis, in a deal worth $3.2M in cash plus rights to receive payments from any royalties or ...
  • Blog Source: californiastemcellreport.blogspot.com
    The California stem cell agency today formally awarded $230 million to 14 teams of scientists in the largest and most ambitious round of research grants in CIRM history. Already the world's largest source of funding for human embryonic ...
Images
 >
 
Videos
 >
 
Report Your News Got a similar story?
Add it to the network!

Or add related content to this report

Cell phones Cell phones use report code: @4504320

Most Popular Reports

Related People

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.